Table 2.
Microbial documentation of infectious events in ICU patients with severe COVID-19
| Microbiological documentation | Community-acquired infections | Early hospital-acquired infections | Late hospital-acquired infections |
|---|---|---|---|
| Bacterial pneumonia | |||
| Acinetobacter baumannii, n (%) | 0 (0) | 1 (3) | 0 (0) |
| Citrobacter koseri, n (%) | 0 (0) | 1 (3) | 1 (3) |
| Escherichia coli, n (%) | 0 (0) | 0 (0) | 1 (3) |
| Haemophilus influenzae, n (%) | 1 (3) | 4 (11) | 0 (0) |
| Klebsiella sp., n (%) | 1 (3) | 3 (8) | 1 (3) |
| Moraxella catarrhalis, n (%) | 0 (0) | 1 (3) | 0 (0) |
| Morganella morganii, n (%) | 0 (0) | 0 (0) | 1 (3) |
| Pseudomonas aeruginosa, n (%) | 1 (3) | 2 (6) | 5 (14) |
| Serratia sp., n (%) | 1 (3) | 0 (0) | 1 (3) |
| Staphylococcus aureus, n (%) | 1 (3) | 2 (6) | 4 (11) |
| Stenotrophomonas maltophila, n (%) | 1 (3) | 0 (0) | 1 (3) |
| Streptococcus constellatus, n (%) | 0 (0) | 0 (0) | 1 (3) |
| Bacteremia | |||
| Corynebacterium sp., n (%) | 1 (3) | 0 (0) | 0 (0) |
| Enterococcus faecalis, n (%) | 0 (0) | 0 (0) | 1 (3) |
| Klebsiella pneumoniae, n (%) | 0 (0) | 0 (0) | 1 (3) |
| Pseudomonas aeruginosa, n (%) | 0 (0) | 0 (0) | 1 (3) |
| Streptococcus mitis, n (%) | 0 (0) | 0 (0) | 1 (3) |
| Fungal pneumoniaa | |||
| Aspergillus fumigatus, n (%) | 1 (3) | 0 (0) | 2 (6) |
| Fungemiaa | |||
| Candida albicans, n (%) | 0 (0) | 0 (0) | 2 (6) |
aAll fungal events are reported in the table, while only first bacterial events are given in the table